Paid Clinical Trials in Beverly Hills, CA
As of June 2026, 170 paid clinical trials are recruiting in Beverly Hills, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Beverly Hills offers studies at sites including Tower Cancer Research Foundation for conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Metastatic Breast Cancer, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Beverly Hills
Trials by drug in Beverly Hills
Filter results
170 clinical trials
↓ Download CSVA Study in Adults With Geographic Atrophy
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Tensi+ for Treating Overactive Bladder
Collection of Training Data for LuminX Probe AI Models
Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Phase 1 Study of C.001 in Retinal Degeneration
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Nicotinamide Mononucleotide Supplementation for Exercise Tolerance Improvement in Healthy Older Adults
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
PhoRTE® Therapy Efficacy: In-Person Versus Telehealth
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
A Study of DII235 in Adults With Elevated Lipoprotein(a)
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
About research studies in Beverly Hills
Beverly Hills has approximately 170 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in Beverly Hills
Researchers run research studies in Beverly Hills, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Tower Cancer Research Foundation | Anatomic Stage II Breast Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 26 |
| Beverly Hills Cancer Center | Metastatic Breast Cancer, Breast Cancer, Non Small Cell Lung Cancer | 15 |
| National Heart Institute | Atherosclerotic Cardiovascular Disease (ASCVD), Heart Failure, Aortic Stenosis | 14 |
| Retina-Vitreous Associates Medical Group | Geographic Atrophy, Diabetic Macular Edema, AMD | 11 |
| Cedars-Sinai Medical Center | Obesity or Overweight, ATTR Amyloidosis Wild Type, ATTR Gene Mutation | 7 |
| Precision NextGen Oncology | Advanced Cancer, Brain Metastases, Adult, Cervical Cancer | 5 |
| Precision NextGen Oncology & Research Center | Endometrial Cancer, Advanced Solid Tumors, CNS Tumor | 5 |
| Precision NextGen Oncology and Research Center | Adenocarcinoma of Lung, Advanced Lung Cancer, Carcinoma, Non-Small-Cell Lung | 4 |
| Cardiovascular Research Foundation of Southern California | ASCVD, ASCVD Management, Atherosclerosis | 3 |
| Cedars-Sinai Cancer Beverly Hills | Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm | 3 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 3 |
| Retina Vitreous Associates Medical Group | Age-related Macular Degeneration (AMD), DME, Diabetic Macular Edema | 3 |
| Amicis Research Center | Atherosclerotic Cardiovascular Disease in Patients With ESKD, Chronic Kidney Diseases, Type 2 Diabetes Mellitus | 2 |
| Cardiovascular Res Found | Aortic Stenosis, Cardiovascular Disease and Lipoprotein(a) | 2 |
| Cedars-Sinai Cancer at Beverly Hills (THO) | Carcinoma, Lung Cancer, Non Small Cell Lung Cancer | 2 |
| GSK Investigational Site | HIV Infections, Multiple Myeloma, Newly Diagnosed Multiple Myeloma | 2 |
| Pacific Oaks Medical Group | HIV Infections, Percutaneous Coronary Intervention, Peripheral Endovascular Intervention | 2 |
| R3 Anti Aging Beverly Hills | Low Back Pain, Osteoarthritis, Knee | 2 |
| UCLA Health Beverly Hills Primary & Specialty Care | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 2 |
| Wallace Rheumatic Study Center | Primary Sjogren's Disease, Systemic Lupus Erythematosus (SLE) | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Amicis Research Center - Beverly Hills | Difficult to Control Hypertension | 1 |
| Amicis Research: Beverly Hills | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
Active & Upcoming Studies in Beverly Hills (2026)
Recruiting trials in Beverly Hills grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (73 active studies)
- Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product, MO-03, in Patients With Early Stage Triple Negative Breast Cancer · Phase 2 · Yuan Yuan
- A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202) · Phase 3 · Bristol-Myers Squibb
Eye & vision (14 active studies)
- Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration · Phase 1, Phase 2 · Eyconis INC.
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
Cardiovascular (13 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Diabetes & metabolic (7 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
HIV / STI (2 active studies)
Neurology & pain (2 active studies)
Mental health & behavior (1 active study)
Common conditions studied in Beverly Hills
- Breast Cancer (7 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Anatomic Stage II Breast Cancer AJCC v8 (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Metastatic Breast Cancer (6 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Heart Failure (5 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Non Small Cell Lung Cancer (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Geographic Atrophy (4 active studies). Recruiting Geographic Atrophy studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Beverly Hills
- AstraZeneca
- AbbVie
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Boehringer Ingelheim
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Beverly Hills. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Beverly Hills
Hipa.ai aggregates every recruiting study in Beverly Hills from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Beverly Hills?
There are approximately 170 recruiting clinical trials in Beverly Hills, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Beverly Hills pay participants?
Most recruiting trials in Beverly Hills compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Beverly Hills?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Beverly Hills?
The most common conditions under active study in Beverly Hills include Breast Cancer (7), Anatomic Stage II Breast Cancer AJCC v8 (6), Metastatic Breast Cancer (6), Heart Failure (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Beverly Hills?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Beverly Hills on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Beverly Hills?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Beverly Hills?
Recruiting research sites in Beverly Hills include Tower Cancer Research Foundation, Beverly Hills Cancer Center, National Heart Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Beverly Hills right now?
The largest active categories in Beverly Hills are Cancer & tumors (73), Eye & vision (14), Cardiovascular (13). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.